STAAR SURGICAL CO — Director's Dealing 2020

Mar 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-03-20

Reporting Person: Hayashida Jon K. (VP, Global Clinical, Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-20	Common Stock	A	7357	$0.00	Acquired	13607	Direct
2020-03-23	Common Stock	S	2813	$26.83	Disposed	10794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-20	Common Stock Options	$27.53	A	15297	Acquired	2030-03-19	Common Stock (15297)	Direct

Footnotes

F1: Award of 7357 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.07 to $27.49, inclusive.

F3: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.